Result of AGM

Summary by AI BETAClose X

Bioventix PLC announced that all resolutions were passed at its Annual General Meeting held on December 4, 2025. The company, which specializes in developing and supplying high-affinity monoclonal antibodies for clinical diagnostics, confirmed the successful outcome of its shareholder meeting. This positive procedural development suggests continued shareholder support for the company's strategic direction and operations.

Disclaimer*

Companies

Bioventix (BVXP)
UK 100

Latest directors dealings